Source: Cell Death & Disease. Unidades: FMRP, FM
Subjects: ANTINEOPLÁSICOS, APOPTOSE, DIFERENCIAÇÃO CELULAR, PROLIFERAÇÃO CELULAR, LEUCEMIA, FATORES DE TRANSCRIÇÃO
ABNT
PEREIRA-MARTINS, Diego Antonio et al. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death & Disease, v. 12, n. 4, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41419-021-03604-z. Acesso em: 10 nov. 2024.APA
Pereira-Martins, D. A., Weinhäuser, I., Coelho-Silva, J. L., Franca-Neto, P. L., Almeida, L. Y., Bianco, T. M., et al. (2021). MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death & Disease, 12( 4), 1-14. doi:10.1038/s41419-021-03604-zNLM
Pereira-Martins DA, Weinhäuser I, Coelho-Silva JL, Franca-Neto PL, Almeida LY, Bianco TM, Silva CL, Franca RF de O, Traina F, Rego EM, Schuringa JJ, Lucena-Araújo AR. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model [Internet]. Cell Death & Disease. 2021 ; 12( 4): 1-14.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41419-021-03604-zVancouver
Pereira-Martins DA, Weinhäuser I, Coelho-Silva JL, Franca-Neto PL, Almeida LY, Bianco TM, Silva CL, Franca RF de O, Traina F, Rego EM, Schuringa JJ, Lucena-Araújo AR. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model [Internet]. Cell Death & Disease. 2021 ; 12( 4): 1-14.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41419-021-03604-z